As DOCK2 has been linked to both IBD and IBD-CRC in the context of its known physiological effect on immune cells, it is a particularly attractive target to study, and to our knowledge, the functional role of DOCK2 on the development of IBD-CRC has not been previously examined. The gene discussed is DOCK2; the disease is colorectal carcinoma.